Merck KGaA raises outlook after forecast-beating Q2 profit

Merck KGaA (MRCG.DE) raised its outlook after posting forecast-beating second quarter profits on Thursday, boosted by demand for its lab gear and supplies from pharma companies making treatments and vaccines against the coronavirus.